Veröffentlichungen

Originalarbeiten

  • Pirner K, Rösler W, Kalden JR, Manger B.
    Langzeitremission nach i.v. Immunglobulintherapie bei erworbener Hemmkörperhämophilie im Rahmen eines systemischen Lupus erythematodes.
    Z Rheumatol 1990; 49: 378-381.

 

  • Potocnik AJ, Menninger H, Yang SY, Pirner K, Krause A, Burmester GR, Bröker BM, Heppt P, Weseloh G, Michels H, Truckenbrodt H, Emmrich F, Kroczek RA.
    Expression of the CD2 activation epitope T11-3 (CD2R) on T cells in rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, and Lyme disease: Phenotypic and functional analysis.
    Scand J Immunol 1991; 34: 351-358.

 

  • Pirner K, Rubbert A, Salinger R, Kalden JR, Manger B.
    Bedeutung des UV-Lichtes in der Pathogenese des SLE: Kasuistik und Diskussion der Literatur.
    Z Rheumatol 1992; 51: 20-24.

 

  • Rubbert A, Pirner K, Wildt L, Kalden JR, Manger B.
    Systemischer Lupus erythematodes und Schwangerschaft.
    Z Rheumatol 1992; 51: 78-86.

 

  • Rubbert A, Marienhagen J, Pirner K, Manger B, Grebmeier J, Engelhardt A, Wolf F, Kalden JR.
    SPECT analysis of cerebral blood flow in the evaluation of CNS involvement in patients with SLE.
    Arthritis Rheum 1992; 36: 1253-1262.
    > PDF herunterladen

 

  • Rubbert A, Pirner K, Wildt L, Kalden JR, Manger B.
    Pregnancy course and complications in patients with systemic lupus erythematosus.
    Am J Reprod Immunol 1992; 28: 205-207.

 

  • Pirner K, Rubbert A, Burmester GR, Kalden JR, Manger B.
    Intravenös verabreichte Immunglobuline beim systemischen Lupus erythematodes: Literaturübersicht und erste klinische Erfahrungen.
    Infusionsther Transfusionsmed 1993; 20, Suppl.1: 131-136.

 

  • Woith W, Nüsslein I, Antoni C, Dejica DI, Winkler TH, Herrmann M, Pirner K, Kalden JR, Manger B.
    A soluble form of the human transferrin receptor is release by activated lymphocytes in vitro.
    Clin Exp Immunol 1993; 92: 537-542.

 

  • Pirner K, Rascu A, Nürnberg W, Rubbert A, Kalden JR, Manger B.
    Evidence for direct anti-heparan-sulphate reactivity in sera of SLE patients.
    Rheumatol Int 1994; 14:1 69-174.
    > PDF herunterladen

 

  • Manger K, Kalden JR, Manger B.
    Cyclosporin A in the treatment of SLE: Results of an open clinical study.
    Brit J Immunol 1996; 35: 669-675.
    > PDF herunterladen

 

  • Rascu A, Manger K, Rubbert A, Manger B, Kalden JR.
    SLE und Schwangerschaft: Eigene Erfahrungen und Literaturübersicht der letzten 15 Jahre.
    Akt Rheumatol 1996; 21: 98-105.
    > PDF herunterladen

 

  • Rascu A, Manger K, Kraetsch HG, Kalden JR, Manger B.
    Osteonecrosis in systemic lupus erythematosus, steroid-induced or  a lupus-dependent manifestation?
    Lupus 1996; 5: 323-327.

 

  • Thieme K, Bitsch TH, Brieger M, Bürckstümmer E, Gromnica-Ihle E, Härter M, Illing MC, Lamparter-Lang R, Liman W, Manger B, Manger K, Peter HH, Roether E, Schneider M, Seelbach H, Specker C.
    Das SLE-Patientenschulungsprogramm – Programminhalt und erste Evaluationsergebnisse.
    Akt Rheumatol, 1997; 22: 98-104.

 

  • Manger K, Repp R, Rascu A, Spriewald B, Wassmuth R, Geiger A, Wenz B, Manger B, Kalden JR, van de Winkel J.
    FcgRIIa Polymorphism In caucasian SLE Patients: Association With Clinical Symptoms.
    Arthritis Rheum 1998; 41: 1181-1189.

 

  • Manger K, Kalden JR.
    Gastritis und Thoraxschmerzen. Churg-Strauss-Vaskulitis.
    Med Klinik 1998; 93: 190.  

 

  • Schwab J, Schwab M, Manger K, Manger B, Wünsch PH, Gottwik M.
    Churg-Strauss-Syndrom mit rechtsventrikulärem Tumor.
    Dtsch Med Wochenschr 1998; 123: 487-493.

 

  • Swaak AJ, van Den Brink HG, Smeenk RJ, Manger K, Kalden JR, Tosi S,et al.
    Systemic lupus erythematosus:clinical features in patients with a disease duration of over 10 years, first evaluation.
    Rheumatology 1999; 38: 953-958.

 

  • Hundt M, Manger K, Dorner T, Grimbacher B, Kalden P, Rascu A, et al.
    Treatment of acute exacerbation of systemic lupus erythematosus with high-dose intravenous immunoglobulin.
    Rheumatology (Oxford) 2000; 39: 1301-2.

 

  • Swaak AJ, van de Brink H, Smeenk RJ, Manger K, Kalden JR, Tosi S, et al.
    Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT).
    Rheumatology 2001; 40: 89-94.    

 

  • Swaak AJ, van den Brink HG, Smeenk RJ, Manger K, Kalden JR, Tosi S, et al. Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation.
    Lupus 2001; 10: 51-8.

 

  • Manger K, Repp R, Jansen M, Geisselbrecht M, Geiger A, Wassmuth R, Manger B, Kalden JR, van de Winkel J.
    Fcgamma receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus: association with clinical symptoms.
    Ann Rheum Dis 2002; 61: 786-92.
    > PDF herunterladen

 

  • Manger K, Manger B, Repp R, Geisselbrecht M, Geiger A, Pfahlberg A, Kalden JR.
    Definition of Risk factors For Death, End Stage renal Disease And Thrombembolic Events In A Monocentric Cohort Of 338 SLE Patients.
    Ann Rheum Dis 2002; 61: 1065-70.

 

  • Manger K, Manger B.
    Konsequenzen der verbesserten Prognose des SLE.
    Z Rheumatol 2002 Oct; 61 (5): 521-31.
    > PDF herunterladen

 

  • Karassa FB, Trikalinos TA, Ioannidis JP., Manger K et.al.
    The Fc gamma RIIIA-F158 allele is a risk factor for the development of lupus nephritis: a meta-analysis.
    Kidney Int 2003; 63: 1475-82.

 

  • Karassa FB, Bijl M, Davies KA, Kallenberg CG, Khamashta MA, Manger K, et al.
    Role of the Fcgamma receptor IIA polymorphism in the antiphospholipid syndrome: an international meta-analysis.
    Arthritis Rheum 2003; 48: 1930-8.
    > PDF herunterladen

 

  • Manger K, Kusus M, Foster C, Ropers D, Daniel WG, Kalden JR, Achenbach S, Manger B.
    Factors associated with coronary artery calcification in young female SLE patients.
    Ann Rheum Dis 2003 Sep; 62 (9): 846-50.
    > PDF herunterladen

 

  • Manger K, Manger B.
    Gibt es eine Indikation fur TNF alpha-Antagonisten bei Kollagenosen?
    Z Rheumatol 2003 Jun; 62 (3): 240-5.
    > PDF herunterladen

 

  • Manger K, Dechant C, Kalden J R, Manger B.
    Clinical images: Periarticular  inflammation in rapidly developing Jaccoud's arthropathy.
    Arthritis Rheum 2004 May; 50 (5): 1700. 
    > PDF herunterladen

 

  • Unger L, Kayser M, Enderlein M, Manger K, Nüsslein H.
    Glucocorticoidtherapie bei Kollagenosen.
    Z Rheumatol 2005 Apr; 64 (3): 162-9.

 

  • Momot T, Ahmadi-Simab K, Gause A, Gross WL,Gromnica-Ihle, E, Peter HH, Manger K, Zeidler H, Schmidt RE, Witte T.
    Lack of association of mannose binding lectin variant alleles with systemic lupus erythematosus.
    Ann Rheum Dis 2006 Feb; 65 (2): 278-9.

 

  • Manger K., Wildt L, Kalden JR, Manger B.
    Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO-Study.
    Autoimmun Rev 2006 Apr; 5 (4): 269-72.

 

  • Ringwald J, Buettner S, Zimmermann R, Eckel K, Weisbach V, Strasser E, Eckstein R, Manger K.
    "Thrombin-activatable fibrinolysis inhibitor and activated factor XII in patients with systemic lupus erythematosus".
    Thromb Res 2007; 119 (1): 129-31.

 

  • Beier F, Balabanov S, Amberger CC, Hartmann U, Manger K, Dietz K, Kötter I, Brummendorf TH.
    Telomere length analysis in monocytes and lymphocytes from patients with systemic lupus erythematosus using multi-color flow-FISH.
    Lupus 2007; 16 (12): 955-62.
    > PDF herunterladen

 

  • Ott HW, Mattle V, Hadziomerovic D, Licht P, Döinghaus K, Rubbert A, Manger K, Manger B, Kalden J, Wildt L.
    Treatment of hereditary angioneurotic oedema (HANE) with tibolone.
    Clin Endocrinol (Oxf) 2007 Feb; 66 (2): 180-4.
    > PDF herunterladen

 

  • Chen JA, Meister S, Urbonaviciute V, Rödel F, Wilhelm S, Kalden JR, Manger K, Voll RE.
    Sensitive detection of plasma/serum DNA in patients with systemic lupus erythematosus.
    Autoimmunity 2007 Jun; 40 (4): 307-10.

 

  • Manger K, Nüsslein H, Schett G, Manger B.
    Rare monogenetic syndromes in rheumatology practice.
    Clin Rheumatol 2009 Jun; 28 (6): 623-30.
    > PDF herunterladen

 

  • Metzler C, Miehle N, Manger K, Iking-Konert C, de Groot K, Hellmich B, Gross WL, Reinhold-Keller E.
    German Network of Rheumatic Diseases. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener`s granulomatosis.
    Rheumatology (Oxford) 2007 Jul; 46 (7): 1087-91.
    > PDF herunterladen

 

  • Liu K et al. Kallikrein genes are associated with lupus and glomerular basement membrane specific antibody-induced nephritis in mice and humans.
    JCI 2010 Apr; 119(4): 911-23.
    > PDF herunterladen

 

  • Nossent J, Kiss E, Rozman, Pokorny G, Manger K et al. Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus.
    Lupus 2010 Apr; 0:1-8
    > PDF herunterladen

 

  • Barbara G Fürnrohr, Sven Wach, Jennifer A Kelly, Karin Manger et al.
    Polymorphisms in the Hsp70 gene locus are genetically associated with systemic lupus erythematosus.
    Ann Rheum Dis 2010; 69: 1983–1989.
    > PDF herunterladen

 

  • Jürgen Rech, Monika Ronneberger, Matthias Englbrecht, Karin Manger et al.
    Successful treatment of adult-onset Still’s disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade.
    Ann Rheum Dis 2010 July.
    > PDF herunterladen

     

  • Manger B, Lindner A, Manger K, Wacker J, Schett G.
    Hypertrophe Osteoarthropathie. Marie-Bamberger-Syndrom.
    Z Rheumatol 2011 Jul; 70 (7): 554-560.
    > PDF herunterladen

 

  • Manger B, Lindner A, Manger K et al.
    Hypertrophic osteoarthropathy
    Z Rheumatol 2011 Sep; (70) 7: 554-+

 

  • Lang V, Englbrecht M, Rech J, Nüsslein H, Manger K, Schuch F, Tony H-P, Fleck M, Manger B, Schett G, Zwerina J.
    Risk of infections in rheumatoid arthritis patients treated with tocilizumab.
    Rheumatology (Oxford) 2012 May; (51) 5: 852-857.
    > PDF herunterladen (advanced access. published Aug. 2011.)

 

  • Proft F, Steinbach S, Dechant C, Manger K et al.
    Gustatory and olfactory function in patients with granulomatosis with polyangiitis (Wegener's).
    Scandinavian Journal of Rheum 2014; 43 (6): 512-518.

 

  • Haschka J, Rech J, Englbrecht M, Manger K et al.
    Reducing Therapy in Rheumatoid Arthritis Patients in Ongoing Remission.
    Arthritis Rheum 2014 Oct; 66: 418.

 

  • Haschka J, Englbrecht M, Manger B, Kleyer A, Manger K et al.
    Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study.
    Ann Rheum Dis 2016 Jan; 75 (1): 45-51.

 

  • Rech J, Hueber AJ, Finzel S, Englbrecht M, Haschka J, Manger B, Manger K et al.
    Prediction of Disease Relapses By Multi-Biomarker Disease Test Activity in Rheumatoid Arthritis Patients Tapering DMARD Treatment.
    Arthritis Rheum 2015 Oct; 67: Supplement: 10 Meeting Abstract: 2584.

 

  • Rech J, Hueber AJ, Finzel S, Manger K et al.
    Prediction of diseases relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment.
    Ann Rheum Dis 2016 Sep; 75 (9): 1637-1644.

 

  • Figueiredo CP, Bang H, Cobra JF, Englbrecht M, Haschka J, Manger B, Manger K et al.
    Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs.
    Ann Rheum Dis 2017 Feb; 76 (2): 399-407.

 

 


Publikationen der Lupus Study Group

  • Hartung K, Coldewey R, Röther E, Pirner K, Specker C, Peter HH, Kalden JR, Lakomek HJ, Deicher H, de Lange GG, and the Members of the SLE study group.
    Immunoglobulin allotypes in systemic lupus erythematosus-results of a central european multicenter study.
    Exp Clin Immunogenet 1991; 8: 11-15.   

 

  • Hartung K, Coldewey R, Röther E, Pirner K, Specker C, Schendel D, Stangel W, Stannat-Kießling S, de Lange G, and the members of the SLE Study Group.
    Immunoglobulin allotypes are not associated with HLA-antigens, autoantibodies and clinical symptoms in systemic lupus erythematosus.
    Rheumatol Int 1991; 11: 179-182. 

 

  • Hartung K, Coldewey R, Krapf F, Lang B, Specker C, Schendel D, Schneider P, Seuchter S, Stangel W, Albert E, Deicher H, and the members of the Deutsche Multizentrische SLE-Studie.
    Hetero- and homozygosity of MHC class II gene products in systemic lupus erythematosus.
    Tissue Antigens 1991; 38: 165-168.

 

  • Seuchter SA, Knapp M, Hartung K, Coleway R, Kalden JR, Lakomek HJ, Peter HH, Deicher H, Baur MP, and the members of the SLE Study Group.
    Testing for association in SLE families.
    Genet Epidemiol 1991; 8: 409-416.

 

  • Hartung K, Ehrfeld H, Lakomek HJ, Coldewey R, Lang B, Krapf F, Müller R, Schendel D, Deicher H, Seelig HP, and the members of the SLE Study Group.
    The genetic basis of Ro and La antibody formation in systemic lupus erythematosus.
    Rheumatol Int 1992; 11: 243-249.

 

  • Hartung K, Coldewey R, Corvetta A, Deicher H, Kalden JR, Krapf F, Lang B, Lakomek HJ, Liedvogel B, Peter HH, Schendel D, Specker C, Stangel W, and the members of the SLE Study Group.
    MHC gene products and anticardiolipin antibodies in systemic lupus erythematosus. Results of a multicenter study.
    Autoimmunity 1992; 13: 95-99.

 

  • Hartung K, Baur MP, Coldeway R, Fricke M, Kalden JR, Lakomek HJ, Peter HH, Schendel D, Schneider PM, Seuchter SA, and the members of the SLE Study Group.
    Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter study.
    J Clin Invest 1992; 90: 1346-1351.

 

  • Ehrfeld H, Hartung K, Renz M, Coldeway R, Deicher H, Fricke M, Kalden JR, Lakomek HJ, Peter HH, Schendel D, and the members of the SLE Study group.
    MHC associations of autoantibodies against recombinant Ro and La proteins in systemic lupus erythematosus.
    Rheumatol Int 1992; 12: 169-173.

 

  • Bettinotti MP, Hartung K, Deicher H, Messer G, Keller E, Weiss EH, Albert ED, and the members of the SLE Study group.
    Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFß-MHC haplotypes.
    Immunogenetics 1993; 37: 449-454.

  

  • Witte T, Hartung K, Sachse C, Fricke M, Buyny S, Deicher H, Kalden JR, Lakomek H, Peter HH, Schmidt RE, and the members of the SLE study group.
    Thrombomodulin in systemic lupus erythematosus: association with clinical and laboratory parameters.
    Rheumatol Int 1999; 19: 8-15.

 

  • Witte T, Hartung K, Sachse C, Matthias T, Fricke M, Kalden JR, Lakomek HJ, Peter HH, Schmidt RE, and the members of the SLE study group.
    Rheumatoid factors in systemic lupus erythematosus: association with clinical and laboratory parameters.
    Rheumatol Int 2000; 19: 109-111.
     

 

 

Übersichtsarbeiten

  • Rubbert A, Pirner K.
    Reaktive Arthritiden.
    Therapiewoche 1992; 43: 456-465.

 

  • Rubbert A, Pirner K.
    Neue Therapiekonzepte in der Rheumatologie.
    Therapiewoche 1994; 44 :1142-1147.

 

  • Rubbert A, Pirner K.
    Mit Gelenkerkrankungen vergesellschaftete Dermatitiden.
    Therapiewoche Dermatol 1993; 23: 309-320.

 

  • Manger K, Bach GL, Müller-Faßbender H, Stock KP.
    Rheuma und Alter: Die senile chronische Polyarthritis.
    Arthritis Rheuma 1995; 15: 8-23.

 

  • Manger K.
    Rheuma und Sport: Belastbarkeit bei systemischen Immunopathien.
    Arthritis Rheuma 1995; 15/4: 22-25.

 

  • Manger K, Kalden JR.
    Neue Therapieprinzipien in der Rheumatologie.
    Arzneimitteltherapie 1996; 14: 167-173.

 

  • Manger K.
    Autoimmunität – Modell der Atherosklerose.
    Target Forum 2002; 1: 34-41.

 

  • Manger K.
    Kommentar zu Prognosefaktoren bei SLE.
    Z. Rheumatol 2002; 61.  

 

  • Manger K, Manger B. Rheumatoide Arthritis: Fortschritte in Diagnostik und Therapie. Der Allgemeinarzt 2010, Nov: 34-35
    > PDF herunterladen
     

 

 

Buchbeiträge

  • Pirner K. 1993:
    Mischkollagenosen. In: Lupus erythematodes – Information für Patienten, Angehörige und Betreuende (Hrsg.: Schneider M.), S. 62-66,
    Steinkopff-Verlag, Darmstadt.

 

  • Manger K, Amann K, 2010:
    „Herzerkrankungen bei rheumatoider Arthritis und anderen Kollagen - zwischen Autoimmunerkrankungen und primären Vaskulitiden“
    In: „Pathologie“, 3. Auflage, Herausgeber W. Remmele, Wiesbaden, G. Klöppel, Kiel, H. Kreipe, Hannover, Springer-Verlag.


  

 

 
Copyright © 2017 – Prof. Dr. Karin Manger – Impressum